Direct-Acting Oral Anticoagulants and Potential Inconsistencies with FDA-Approved Dosing for Non-Valvular Atrial Fibrillation: A Retrospective Real-World Analysis Across Nine US Healthcare Systems.

Autor: DeLor B; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA. bonnie.delor@pfizer.com., Glover JJ; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Hartman TJ; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Manzey LL; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Ateya M; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Kelsh S; Corewell Health/Ferris State University, Grand Rapids, MI, USA., Taylor K; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Zemrak WR; MaineHealth, Portland, ME, USA., Gowen JR; Mass General Brigham - Wentworth Health Partners, Dover, NH, USA., Parks A; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Gust C; ThedaCare, Neenah, WI, USA., Medico C; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Akpoji UC; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Naylor S; MetroHealth, Cleveland, OH, USA., Chou CW; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Fakelmann G; Baptist Health, Louisville, KY, USA., Hart S; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Wiethorn EE; Indiana University Health, Indianapolis, IN, USA., Trinh T; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Wilson WW; Parkview Health, Fort Wayne, IN, USA., Bowen R; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Stanton J; Premier Health, Dayton, OH, USA., Duvall L; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA., Davis LT; Pfizer Inc, 66 Hudson Blvd E, New York, NY, 10001, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.

Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60-120 Kilograms.

Autor: Wiethorn EE; Department of Pharmacy Services, Medical University of South Carolina, 150 Ashley Avenue, MSC 584, Charleston, SC, 29425, USA. wiethorn@musc.edu., Bell CM; Department of Pharmacy Services, Medical University of South Carolina, 150 Ashley Avenue, MSC 584, Charleston, SC, 29425, USA., Wiggins BS; Department of Pharmacy Services, Medical University of South Carolina, 150 Ashley Avenue, MSC 584, Charleston, SC, 29425, USA.

Publikováno v: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2021 Sep; Vol. 21 (5), pp. 545-551. Date of Electronic Publication: 2021 Mar 30.